R. Ford

27.1k total citations
149 papers, 4.2k citations indexed

About

R. Ford is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, R. Ford has authored 149 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Pathology and Forensic Medicine, 46 papers in Immunology and 38 papers in Oncology. Recurrent topics in R. Ford's work include Lymphoma Diagnosis and Treatment (51 papers), Chronic Lymphocytic Leukemia Research (34 papers) and Immune Cell Function and Interaction (23 papers). R. Ford is often cited by papers focused on Lymphoma Diagnosis and Treatment (51 papers), Chronic Lymphocytic Leukemia Research (34 papers) and Immune Cell Function and Interaction (23 papers). R. Ford collaborates with scholars based in United States, Canada and China. R. Ford's co-authors include Lan V. Pham, Archito T. Tamayo, Abby Maizel, Linda C. Yoshimura, Piao Lo, Yen-Chiu Lin-Lee, Sherri Chubb, WN Hittelman, L. E. Robertson and Jan A. Burger and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

R. Ford

143 papers receiving 4.1k citations

Peers

Countries citing papers authored by R. Ford

Since Specialization

Citations

This map shows the geographic impact of R. Ford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Ford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Ford more than expected).

Fields of papers citing papers by R. Ford

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Ford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Ford. The network helps show where R. Ford may publish in the future.

Co-authorship network of co-authors of R. Ford

This figure shows the co-authorship network connecting the top 25 collaborators of R. Ford. A scholar is included among the top collaborators of R. Ford based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Ford. R. Ford is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas 2018 ·Clinical Cancer Research ·Lan V. Pham, Shengjian Huang, Hui Zhang, Jun Zhang, Taylor Bell, Shouhao Zhou, (unknown), Zhiyong Ding, Laura Lam, Jason R. Westin, R. Eric Davis, Ken H. Young, L. Jeffrey Medeiros, R. Ford, Krystle Nomie, Leo Yu Zhang, Michael Wang	63
2	Immunologic Competence of Alveolar Cells 2015 ·American Review of Respiratory Disease ·R. Ford, Charles Kuhn	0
3	Establishment and characterization of a novel MYC/BCL2 “double-hit” diffuse large B cell lymphoma cell line, RC 2015 ·Journal of Hematology & Oncology ·Lan V. Pham, Gary Lu, Archito T. Tamayo, Juan Chen, Pramoda Challagundla, Jeffrey L. Jorgensen, L. Jeffrey Medeiros, R. Ford	9
4	In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome 2013 ·Molecular Cancer Therapeutics ·Liang Zhang, Lan V. Pham, Kate J. Newberry, Zhishuo Ou, (unknown), Jianfei Qian, Luhong Sun, Marzenna Blonska, Yun You, Jing Yang, Xin Lin, (unknown), Archito T. Tamayo, J. Jack Lee, R. Ford, Xiurong Zhao, Larry W. Kwak, Qing Yi, Michael Wang	22
5	Drug Screening Reveals That Ibrutinib (PCI-32765) Exhibits Synergy With BCL-2 and Proteasome Inhibitors In Models Of Mantle Cell Lymphoma (MCL) and Chronic Lymphocytic Leukemia (CLL) 2013 ·Blood ·Mark J. Axelrod, Zhishuo Ou, Liang Zhang, Vicki L. Gordon, (unknown), Archito T. Tamayo, R. Ford, Lan V. Pham, Michael J. Weber, Michael E. Williams, Michael Wang	5
6	TOPICAL WORKSHOP ON LOW RADIOACTIVITY TECHNIQUES: LRT-2010 2011 ·R. Ford	4
7	Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21) 2011 ·Leukemia ·Ηλίας Δράκος, (unknown), George Z. Rassidakis, Ellen Schlette, J. Li, Francois X. Claret, R. Ford, Francisco Vega, L. Jeffrey Medeiros	54
8	Low background techniques in XMASS 2011 ·AIP conference proceedings ·Atsushi Takeda, R. Ford	1
9	Degrasyn Potentiates the Antitumor Effects of Bortezomib in Mantle Cell Lymphoma Cells In vitro and In vivo : Therapeutic Implications 2010 ·Molecular Cancer Therapeutics ·Lan V. Pham, Archito T. Tamayo, Changping Li, William G. Bornmann, Waldemar Priebe, R. Ford	46
10	Side population of a murine mantle cell lymphoma model contains tumour‐initiating cells responsible for lymphoma maintenance and dissemination 2009 ·Journal of Cellular and Molecular Medicine ·Francisco Vega, (unknown), Jeong Hee Cho‐Vega, (unknown), Shuguang Ma, Ruiyu Wang, Asha S. Multani, Ηλίας Δράκος, Lan V. Pham, (unknown), Long Shen, Julian L. Ambrus, L. Jeffrey Medeiros, R. Ford	14
11	Development of Autoimmunity in IL-14α-Transgenic Mice 2006 ·The Journal of Immunology ·Long Shen, Chongjie Zhang, Tao Wang, Stephen R. Brooks, R. Ford, Yen Chiu Lin-Lee, (unknown), Vijay Kumar, Lisa Martin, Ping Liang, John K. Cowell, Julian L. Ambrus	74
12	Mediastinal follicular dendritic cell sarcoma involving bone marrow: a case report and review of the literature 2006 ·Annals of Diagnostic Pathology ·Liuyan Jiang, Joan H. Admirand, César A. Moran, R. Ford, Carlos E. Bueso‐Ramos	21
13	Nuclear Localization in the Biology of the CD40 Receptor in Normal and Neoplastic Human B Lymphocytes 2006 ·Journal of Biological Chemistry ·Yen-Chiu Lin-Lee, Lan V. Pham, Archito T. Tamayo, Lingchen Fu, Haijun Zhou, Linda C. Yoshimura, Glenn L. Decker, R. Ford	43
14	Inhibition of Constitutive NF-κB Activation in Mantle Cell Lymphoma B Cells Leads to Induction of Cell Cycle Arrest and Apoptosis 2003 ·The Journal of Immunology ·Lan V. Pham, Archito T. Tamayo, Linda C. Yoshimura, Piao Lo, R. Ford	266
15	Quantitative Real-Time Polymerase Chain Reaction for Detection of Circulating Cells with T(14;18) in Volunteer Blood Donors and Patients with Follicular Lymphoma 2002 ·Leukemia & lymphoma ·Apostolia M. Tsimberidou, (unknown), R. Ford, Benjamin Lichtiger, L. Jeffrey Medeiros, Peter McLaughlin, Fernando Cabanillas, Andreas H. Sarris	17
16	Fas/APO-1 Expression and Function on Malignant Cells of Hematologic and Nonhematologic Origin 1993 ·Journal of Immunotherapy ·Laurie B. Owen‐Schaub, (unknown), R. Ford	71
17	Chromosome 17p and p53 changes in lymphoma 1991 ·British Journal of Haematology ·Maria Alma Rodriguez, R. Ford, A Goodacre, P Selvanayagam, Fernando Cabanillas, A. B. Deisseroth	27
18	Growth factor-mediated tumor cell proliferation in hairy cell leukemia. 1985 ·The Journal of Experimental Medicine ·R. Ford, Linda C. Yoshimura, James P. Morgan, (unknown), R Montagna, Abby Maizel	43
19	Manual para viajeros por España y lectores en casa: observaciones generales 1982 ·Dialnet (Universidad de la Rioja) ·R. Ford, Jesús Francisco Jordá Pardo, (unknown)	4
20	Human T lymphocyte/monocyte interaction in response to lectin: kinetics of entry into the S-phase. 1981 ·The Journal of Immunology ·Abby Maizel, Shashi Mehta, S M Hauft, D Franzini, Lawrence B. Lachman, R. Ford	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact